Table of Contents Author Guidelines Submit a Manuscript
International Journal of Otolaryngology
Volume 2018, Article ID 2132781, 6 pages
https://doi.org/10.1155/2018/2132781
Research Article

Oncological and Functional Evaluation of Open Conservation Surgery for Hypopharyngeal Cancer with/without Reconstruction

1Department of Otolaryngology, Saitama Medical Center, Saitama Medical University, Saitama, Japan
2Department of Head and Neck Oncology, National Cancer Center Hospital, Tokyo, Japan

Correspondence should be addressed to Tsutomu Nomura; pj.en.ten-os.5cb@arumon-t

Received 2 July 2017; Revised 28 January 2018; Accepted 12 February 2018; Published 26 March 2018

Academic Editor: Holger Sudhoff

Copyright © 2018 Tsutomu Nomura et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Objectives. Oncological and functional results of open conservation surgery for hypopharyngeal cancer have been desired. Methods. We performed a chart review of 33 patients with hypopharyngeal cancer who underwent open conservation surgery. Oncological and functional results were evaluated in surgery with primary closure (Group A) and surgery with reconstruction (Group B). Postoperative functions were evaluated by interval to resumption of oral intake, Functional Outcome Swallowing Scale (FOSS) and Communication Scale (CS). Results. Five-year disease-specific and overall cumulative survival rates by Kaplan-Meier method for all cases were 95.7% and 82.3%, respectively. Duration from surgery to full oral intake was 12 days in Group A and 14 days in Group B. FOSS rates were 83.3 in Group A and 95.5 in Group B. CS was 0 in both groups. Conclusion. Oncological and functional results of open conservation surgery were comparable to those with transoral surgery and chemo/radiotherapy. Our technique represents a reliable treatment for hypopharyngeal cancer.

1. Introduction

Hypopharyngeal cancer (HPC) is one of the most aggressive cancers of the head and neck and shows poor prognosis [1]. Most patients already show advanced-stage disease by the time of diagnosis, and the complicated anatomy of this region makes function-preserving treatment difficult. For decades, the standard treatment for tumors involving the hypopharynx has involved radical surgery and postoperative radiotherapy (RT) [2]. Recently, initial surgery has decreased and chemoradiotherapy (CRT) has become the main treatment with the purpose of functional preservation [3]. Although oncological and functional outcomes of CRT are acceptable, with the exception of throat dryness and laryngeal edema, CRT needs a long treatment period (around 2 months or longer) and good renal function and can only be performed once at a single site usually. On the other hand, surgery is becoming more and more limited to radical surgery or early-stage endoscopic and transoral surgery. Transoral robotic surgery [4] and transoral resection [57] have recently been introduced and are gaining popularity. Transoral resection is one of the treatments of choice, but achieving good positioning can be difficult and special instruments are needed. Robotic surgery may be superior to other approaches, but is costly, which is problematic in Japan. In our institute, open conservation surgery has been performed for a long time. No previous studies have reported on postoperative function after open conservation surgery. To address the prejudice of poor postoperative function after open surgery, this study evaluated functional and oncological results of cases treated using open conservation surgery.

2. Materials and Methods

We performed a chart review of 33 patients with HPC who underwent open conservation surgery in the Department of Head and Neck Oncology at National Cancer Center Hospital (NCC) between July 2007 and December 2012. Each preoperative stage was determined using physical examination, endoscopy, computed tomography (CT), and other examinations with 7th UICC classification [8]. Our criteria for open conservation surgery were as follows. Favorable patient factors include age less than 80 years; performance status of 0 (fully active, able to carry on all predisease performance without restriction) to 1 (restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature); good lung function (with normal spirometry and chest X-ray); no history of aspiration; and good prognosis for swallowing rehabilitation (the patients with eating normal food before surgery, good dentition, and having a motivation of eating). Favorable T factors included mobility of bilateral vocal cords and no deep invasion into the arytenoid or postcricoid areas. If the contralateral vocal cord was intact, surgery was indicated despite T3 or T4 status. For the N factor, any status other than N3 was considered favorable. The following surgical procedure was performed for open conservation surgery.

First, we utilized a suprahyoid or posterior approach depending on the tumor sites (Figure 1). Approach sites is selected carefully not injuring tumors and achieving safety margins. Laryngeal cartilage was dissected as shown in Figure 1(a) in all cases. And hyoid bone was cut as figure in almost of cases.

Figure 1: (a) Hyoid bone and laryngeal cartilage were dissected as figure drawings. (b) The tumor was exposed. (c) Lugol’s solution (iodine-glycerin) was used. (d) The tumor was resected with more than 5 mm margin.

To check the tumor margins, Lugol’s solution (iodine-glycerin) was used (Figure 1(c)). A surgical margin of more than 5 mm was considered safe. To ensure free margins, frozen sections from at least 4 directions were examined histopathologically. Smaller defects were closed primarily, and larger defects were reconstructed using a radial forearm flap or jejunal flap. Patients with open conservation surgery with primary closure (Group A) underwent 1 bilateral and 6 unilateral neck dissections. Patients with open conservation surgery with reconstruction (Group B) underwent 9 bilateral and 12 unilateral neck dissections. Postoperative irradiation was performed in 7 cases from Group B and no cases from Group A. The distribution of all cases is listed in Table 1. Histological examination identified all cases as squamous cell carcinoma (SCC). TN classifications of all cases are listed in Table 2. All patients were followed for a minimum of 2 years or until death. Mean duration of follow-up was 50.0 months.

Table 1: Distribution of patients.
Table 2: TN and stage classification.

In all cases, the interval from surgery to resumption of full oral intake was recorded. Postoperative function was evaluated using the Functional Outcome Swallowing Scale (FOSS) criteria [9], 1 year after surgery. Symptom criteria were as follows: stage 0, normal function and asymptomatic; stage 1, normal function with episodic or daily symptoms of dysphagia; stage 2, compensated abnormal function manifesting as significant dietary modifications or prolonged mealtime (without weight loss or aspiration); stage 3, decompensated abnormal function with weight loss of 10% of body weight over 6 months caused by dysphagia or daily cough, gagging, or aspiration during meals; stage 4, severely decompensated abnormal function with weight loss of 10% of body weight over 6 months caused by dysphagia or severe aspiration with bronchopulmonary complications and nonoral feeding for most nutrition; and stage 5, nonoral feeding for all nutrition.

FOSS rate was counted as the rate of grades 0 and 1 in total cases.

The Communication Scale (CS) was used for evaluating speech function [10]. Symptom criteria were as follows: stage 0, normal speech; stage 1, minimally dysphonic; stage 2, grossly dysphonic; stage 3, near-total loss of speech; stage 4, requiring speech aid; stage 5, no speech. Comparative statistical analysis, overall survival (OS), and disease-specific survival (DSS) rates by Kaplan-Meier analysis and log-rank test were evaluated using SPSS version 19.0 software (SPSS, Chicago, IL).

3. Results

3.1. Therapeutic Outcomes

Therapeutic outcomes are listed in Table 3. In Group A, mean operation time was 2 h 16 min (range, 1 h 5 min–4 h 30 min), and mean blood loss was 28 ml (range, 2–123 ml). In Group B, mean operation time was 7 h 24 m (range, 5 h 25 min–9 h 35 min), and mean blood loss was 254 ml (range, 2–710 ml).

Table 3: Background for surgery and posttreatment function.

In reconstructed patients, no flap failure was found.

In terms of oncology, one of the two recurrences in Group A was treated by Endoscopic Mucosal Resection (EMR) and the other in a second open conservation surgery. In Group B, the 4 cases of recurrence were treated by irradiation, and control without recurrence was achieved in 3 of those 4 cases. Five-year DSS rates in Groups A and B were 100% and 92.9%, respectively. OS rates in Groups A and B were 73.3% and 88.4%, respectively. Five-year DSS and OS rates for the total cohort were 95.7% and 82.3%, respectively. There is no statistic difference in two groups.

3.2. Functional Analysis

Mean interval from surgery to full oral intake was 12 days (range, 6–862 days) in Group A and 14 days (range, 8–77 days) in Group B. Although the interval to full oral intake was long in one case from Group A because of fistula formation, the mean interval to full oral intake tended to be longer in Group B, although the difference was not significant. In terms of CS score, all cases were classified as grade 0. FOSS rates were 83.3 in Group A and 95.5 in Group B. Functional results tended to be relatively better in Group B than in Group A, but no significant difference was evident.

4. Discussion

Evidence as to whether surgery or CRT is more effective against HPSCC is lacking, with the exception of treatment for advanced resectable tumor. The choice of treatment thus depends on the individual institutions. Open conservation surgery offers numerous advantages over transoral resection. No special instruments are needed, and direct observation is possible intraoperatively. The ease of access to the posterior cricoid and caudal regions is also beneficial. If neck dissection is needed, such operations can be performed through the same incision. However, transoral resection carries a risk of fistula formation if neck dissection is undertaken simultaneously. Compared with RT, the very short treatment period and lack of late complications with open surgery are advantageous. Given this background, we compared our oncological and functional results with other modalities of RT and transoral resection as laryngeal preserving modalities.

From an oncological perspective, open conservation surgery had wide range of survival rate [1128]. Ogura et al. [11] reported the use of partial laryngopharyngectomy (PLP), supracricoid hemilaryngopharyngectomy (SCHLP), and supraglottic hemilaryngopharyngectomy (SGHLP) techniques for early to relatively advanced-stage hypopharynx carcinoma (Table 4). With those techniques, the resection wound underwent primary suturing. With large defects, stenosis of the pharynx and functional loss may also result. After the free flap technique became standard, although small defects underwent primary closure, larger wounds were reconstructed using free flaps as in our technique. No stenosis forms if a free flap is used. In the present study, 5-year OS and DSS rates were 82.3% and 95.7%, representing better results than other open conservation surgeries. Czaja and Gluckman [14] reported a 5-year OS rate of 33.4% for early-stage cancer and commented that surgery with wide resection offered better prognosis than partial pharyngectomy. However, the prognosis depends on the technique and wide resection is not needed if margins are adequate. Compared with transoral resection, few reports have provided survival data, and Tomifuji et al. [6] reported 5-year OS and DSS rates of 77% and 95% for T1 to T3 cases. Such results are excellent and comparable to our own. Reports of CRT and RT seem to skew toward advanced cases. A few reports have showed stage distributions similar to our cases. Mok et al. [29] compared outcomes between intensity-modulated RT (IMRT) and conventional RT. That report described 181 cases in T1 to T4. The 3-year OS rates for IMRT or 3D-RT were 50% and 52%, respectively. Furukawa et al. [30] reported the 5-year OS rate for concurrent chemoradiotherapy (CCRT) after poor response to induction chemotherapy (ICT) was 53.6%, compared to 68.7% with good response to ICT. Nishimura et al. [31] reported a 5-year survival rate of 81% for T1 and T2 hypopharyngeal cases. From these CRT case studies, our 5-year OS of 82.3% was acceptable and relatively better than the data of Nishihara et al. including only T1-2. With a view to improving the results of open conservation surgery, we used frozen sections for intraoperative pathological analysis. This system worked well in our study, and all surgeries were performed safely. The recurrence rate was slightly higher in Group A than in Group B. Four cases of open conservation surgery requiring salvage were able to undergo further function-preserving surgery. Whereas recurrences in RT patients required radical surgery, salvage surgery for open conservation surgery could be performed conservatively. Open conservation surgery thus seems advantageous from the perspective of salvage risk.

Table 4: Review of the literature.

In terms of oral intake, all surgical patients were taking food orally within 2 weeks. Open surgeries appear to represent a reliable choice for oral nutrition. Tomifuji et al. [6] reported an interval of 9 days until swallowing after surgery in transoral videolaryngoscopic surgery (TOVS). These data were relatively better than our own, but percutaneous endoscopic gastroscopy (PEG) was necessary in some cases. Tomifuji et al. also reported that 89.8% of patients were less than stage 2 in FOSS. These data were almost the same as our data (Group A, 83.3%; Group B, 95.5%). Our open surgery technique is thus comparable to TOVS from a functional perspective. Few reports have provided functional data for RT and CRT. Recently, many patients have been treated using IMRT. Daly et al. [32] reported the efficacy of IMRT. Szuecs et al. [33] and Peponi et al. [34] reported on swallowing and vocal function after RT, identifying long-term swallowing dysfunction in patients, particularly those on CRT regimens. Although no significant differences were identified, FOSS data tended to be better in Group B than in Group A. Reconstruction surgery takes longer than primary suture, but reconstruction is worthwhile for securing good postoperative function.

5. Conclusion

Open conservation surgery does not require special instruments or a long time for treatment with acceptable oncological and functional outcomes. This option is useful in select patients, even in the era of transoral surgery, and should be reevaluated.

Consent

Patients understood the aim of our study and signed the informed consent.

Conflicts of Interest

The authors declare that they have no conflicts of interest.

References

  1. H. T. Hoffman, L. H. Karnell, G. F. Funk, R. A. Robinson, and H. R. Menck, “The National Cancer Data Base Report on Cancer of the Head and Neck,” Archives of Otolaryngology–Head & Neck Surgery, vol. 124, no. 9, p. 951, 1998. View at Publisher · View at Google Scholar
  2. S. A. ElBadawi, H. Goepfert, G. H. Fletcher, J. Herson, and M. J. Oswald, “Squamous cell carcinoma of the pyriform sinus,” The Laryngoscope, vol. 92, no. 4, pp. 357–364, 1982. View at Google Scholar · View at Scopus
  3. R. P. Takes, P. Strojan, C. E. Silver et al., “Current trends in initial management of hypopharyngeal cancer: the declining use of open surgery,” Head & Neck, vol. 34, no. 2, pp. 270–281, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. Y. M. Park, W. S. Kim, A. De Virgilio, S. Y. Lee, J. H. Seol, and S.-H. Kim, “Transoral robotic surgery for hypopharyngeal squamous cell carcinoma: 3-Year oncologic and functional analysis,” Oral Oncology, vol. 48, no. 6, pp. 560–566, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. I. Tateya, A. Shiotani, Y. Satou et al., “Transoral surgery for laryngo-pharyngeal cancer—the paradigm shift of the head and cancer treatment,” Auris Nasus Larynx, vol. 43, no. 1, pp. 21–32, 2016. View at Publisher · View at Google Scholar · View at Scopus
  6. M. Tomifuji, K. Araki, T. Yamashita, and A. Shiotani, “Transoral videolaryngoscopic surgery for oropharyngeal, hypopharyngeal, and supraglottic cancer,” European Archives of Oto-Rhino-Laryngology, vol. 271, no. 3, pp. 589–597, 2014. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Tomifuji, K. Araki, T. Yamashita et al., “Risk factors for dysphagia after transoral videolaryngoscopic surgery for laryngeal and pharyngeal cancer,” Head & Neck, vol. 38, no. 2, pp. 196–201, 2016. View at Publisher · View at Google Scholar · View at Scopus
  8. S. Chae, A. Lee, and J.-H. Lee, “The effectiveness of the new (7th) UICC N classification in the prognosis evaluation of gastric cancer patients: A comparative study between the 5th/6th and 7th UICC N classification,” Gastric Cancer, vol. 14, no. 2, pp. 166–171, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. J. R. Salassa, “A functional outcome swallowing scale for staging oropharyngeal dysphagia,” Digestive Diseases, vol. 17, no. 4, pp. 230–234, 1999. View at Publisher · View at Google Scholar · View at Scopus
  10. D. G. Grant, J. R. Salassa, M. L. Hinni, B. W. Pearson, and W. C. Perry, “Carcinoma of the tongue base treated by transoral laser microsurgery, part one: Untreated tumors, a prospective analysis of oncologic and functional outcomes,” The Laryngoscope, vol. 116, no. 12, pp. 2150–2155, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. J. H. Ogura, J. E. Marks, and R. B. Freeman, “Results of conservation surgery for cancers of the supraglottis and pyriform sinus,” The Laryngoscope, vol. 90, no. 4, pp. 591–600, 1980. View at Google Scholar · View at Scopus
  12. O. Laccourreye, A. Mérite-Drancy, D. Brasnu et al., “Supracricoid hemilaryngopharyngectomy in selected pyriform sinus carcinoma staged as T2,” The Laryngoscope, vol. 103, no. 12, pp. 1373–1379, 1993. View at Google Scholar · View at Scopus
  13. D. Chevalier, J.-B. Watelet, J.-A. Darras, and J.-J. Piquet, “Supraglottic hemilaryngopharyngectomy plus radiation for the treatment of early lateral margin and pyriform sinus carcinoma,” Head & Neck, vol. 19, no. 1, pp. 1–5, 1997. View at Publisher · View at Google Scholar · View at Scopus
  14. J. M. Czaja and J. L. Gluckman, “Surgical Management of Early-Stage Hypopharyngeal Carcinoma,” Annals of Otology, Rhinology & Laryngology, vol. 106, no. 11, pp. 909–913, 1997. View at Publisher · View at Google Scholar
  15. H. E. Eckel, S. Staar, P. Volling, C. Sittel, M. Damm, and M. Jungehuelsing, “Surgical treatment for hypopharynx carcinoma: feasibility, mortality, and results,” Otolaryngology—Head and Neck Surgery, vol. 124, no. 5, pp. 561–569, 2001. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Makeieff, G. Mercente, E. Jouzdani, R. Garrel, L. Crampette, and B. Guerrier, “Supraglottic hemipharyngolaryngectomy for the treatment of T1 and T2 carcinomas of laryngeal margin and piriform sinus,” Head & Neck, vol. 26, no. 8, pp. 701–705, 2004. View at Publisher · View at Google Scholar · View at Scopus
  17. T. Asakage, K. Nakao, M. Sugasawa, and M. Mochiki, “Partial pharyngectomy for hypopharyngeal carcinoma,” Toukeibu Gan, vol. 30, no. 4, pp. 570–574, 2004. View at Publisher · View at Google Scholar · View at Scopus
  18. I. Plouin-Gaudon, B. Lengelé, G. Desuter et al., “Conservation laryngeal surgery for selected pyriform sinus cancer,” European Journal of Surgical Oncology, vol. 30, no. 10, pp. 1123–1130, 2004. View at Publisher · View at Google Scholar · View at Scopus
  19. R. Kania, D. Brasnu, S. Hans, E. De Mones, D. Garcia, and O. Laccourreye, “Supracricoid hemilaryngopharyngectomy in patients with invasive squamous cell carcinoma of the pyriform sinus. Part II: Incidence and consequences of local recurrence,” Annals of Otology, Rhinology & Laryngology, vol. 114, no. 2, pp. 95–104, 2005. View at Publisher · View at Google Scholar · View at Scopus
  20. K. Matsuura, Y. Asada, K. Kato, M. Yamazaki, and S. Saijo, “Relationship between extent of resection and reconstruction in laryngeal preservation surgery for hypopharyngeal cancer,” Journal of Japan Society for Head and Neck Surgery, vol. 19, no. 2, pp. 111–118, 2009. View at Publisher · View at Google Scholar
  21. S. Hirano, I. Tateya, M. Kitamura et al., “Organ preservation surgery for advanced hypopharyngeal cancer.,” Acta Oto-Laryngologica, Supplement, no. 563, pp. 50–55, 2010. View at Google Scholar · View at Scopus
  22. Y. Seino, T. Iino, K. Aoki et al., “Laryngeal preservation surgery of hypopharyngeal carcinoma,” Toukeibu Gan, vol. 36, no. 1, pp. 57–61, 2010. View at Publisher · View at Google Scholar
  23. Y. C. Lim, H. M. Jeong, H. A. Shin, and E. C. Choi, “Larynx-preserving partial pharyngectomy via lateral pharyngotomy for the treatment of small (T1~2) hypopharyngeal squamous cell carcinoma,” Clinical and Experimental Otorhinolaryngology, vol. 4, no. 1, pp. 44–48, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. Y.-H. Joo, K.-J. Cho, J.-O. Park, I.-C. Nam, and M.-S. Kim, “Role of larynx-preserving partial hypopharyngectomy with and without postoperative radiotherapy for squamous cell carcinoma of the hypopharynx,” Oral Oncology, vol. 48, no. 2, pp. 168–172, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. T. Kurita, K. Yoshino, T. Fujii, M. Suzuki, and H. Uemura, “A clinical study of larynx preserved partial pharyngectomy with reconstruction using a free flap-with special reference to long-term results,” Japanese Journal of Head and Neck Cancer, vol. 38, no. 4, pp. 385–389, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. T. Ono, T. Yoshidumi, K. Hirano, W. Ooyama, and S. Ebihara, “Clinical study of larynx-preserving partial pharyngectomy for hypopharyngeal squamous cell carcinoma,” Journal of Japan Society for Head and Neck Surgery, vol. 22, no. 3, pp. 293–296, 2012. View at Publisher · View at Google Scholar
  27. E.-J. Chung, J.-J. Lee, H.-S. Kim et al., “Alternative treatment option for hypopharyngeal cancer: Clinical outcomes after conservative laryngeal surgery with partial pharyngectomy,” Acta Oto-Laryngologica, vol. 133, no. 8, pp. 866–873, 2013. View at Publisher · View at Google Scholar · View at Scopus
  28. C.-L. Kuo, T.-L. Lee, and P.-Y. Chu, “Conservation surgery for hypopharyngeal cancer: Changing paradigm from open to endoscopic,” Acta Oto-Laryngologica, vol. 133, no. 10, pp. 1096–1103, 2013. View at Publisher · View at Google Scholar · View at Scopus
  29. G. Mok, I. Gauthier, H. Jiang et al., “Outcomes of intensity-modulated radiotherapy versus conventional radiotherapy for hypopharyngeal cancer,” Head & Neck, vol. 37, no. 5, pp. 655–661, 2015. View at Publisher · View at Google Scholar · View at Scopus
  30. T. Furukawa, S. Iwae, Y. Hirayama et al., “A clinical analysis of hypopharyngeal carcinoma: Single-institution outcomes,” Japanese Journal of Head and Neck Cancer, vol. 39, no. 4, pp. 460–465, 2013. View at Publisher · View at Google Scholar · View at Scopus
  31. H. Nishimura, R. Sasaki, K. Yoshida et al., “Radiotherapy for Stage i or II hypopharyngeal carcinoma,” Journal of Radiation Research, vol. 53, no. 6, pp. 892–899, 2012. View at Publisher · View at Google Scholar · View at Scopus
  32. M. E. Daly, Q.-T. Le, A. K. Jain et al., “Intensity-modulated radiotherapy for locally advanced cancers of the larynx and hypopharynx,” Head & Neck, vol. 33, no. 1, pp. 103–111, 2011. View at Publisher · View at Google Scholar · View at Scopus
  33. M. Szuecs, T. Kuhnt, C. Punke et al., “Subjective voice quality, communicative ability and swallowing after definitive radio(chemo)therapy, laryngectomy plus radio(chemo)therapy, or organ conservation surgery plus radio(chemo)therapy for laryngeal and hypopharyngeal cancer,” Journal of Radiation Research, vol. 56, no. 1, pp. 159–168, 2014. View at Publisher · View at Google Scholar · View at Scopus
  34. E. Peponi, C. Glanzmann, B. Willi, G. Huber, and G. Studer, “Dysphagia in head and neck cancer patients following intensity modulated radiotherapy (IMRT),” Journal of Radiation Oncology, vol. 6, no. 1, article no. 1, 2011. View at Publisher · View at Google Scholar · View at Scopus